Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction

Diabetes Technology and Therapeutics

Volumn 15, Issue 11, 2013, Pages 948-953

  Casellini, Carolina M ^a   Parson, Henri K ^a   Richardson, Margaret S ^a   Nevoret, Marie L ^a   Vinik, Aaron I ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTONOMIC DYSFUNCTION; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC PATIENT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IONTOPHORESIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SKIN CONDUCTANCE; SMALL FIBER NEUROPATHY; VISUAL ANALOG SCALE;

ADULT; AUTONOMIC NERVOUS SYSTEM; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; FOOT; GALVANIC SKIN RESPONSE; HAND; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSORY THRESHOLDS; SKIN; VISUAL ANALOG SCALE;

EID: 84887125544     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0129     Document Type: Article

References (26)

1. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P: Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33:2285-2293.
2. Alport AR, Sander HW: Clinical approach to peripheral neuropathy: anatomic localization and diagnostic testing. Continuum (Minneap Minn ) 2012;18:13-38.
3. Vinik A, Nevoret M-L: Neuropathy in prediabetes and the metabolic syndrome. Prevention of type 2 diabetes. In: LeRoith D, ed. Prevention of Type 2 Diabetes: From Science to Therapy. New York: Springer Science & Business Media, 2012:117-142.
4. McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW: Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 1998;55:1513-1520.
5. Fealey RD, Low PA, Thomas JE: Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc 1989;64:617-628.
6. Illigens BM, Gibbons CH: Sweat testing to evaluate autonomic function. Clin Auton Res 2009;19:79-87.
7. Vinik AI, Nevoret ML, Casellini CM, Parson HK: Neurovascular function and sudorimetry in health and disease. Curr Diab Rep 2013 May 17 [Epub ahead of print]. doi: 10.1007/s11892-013-0392-x.
8. Mayaudon H, Miloche PO, Bauduceau B: A new simple method for assessing sudomotor function: relevance in type 2 diabetes. Diabetes Metab 2010;36:450-454.
9. Gin H, Baudoin R, Raffaitin CH, Rigalleau V, Gonzalez C: Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation. Diabetes Metab 2011;37:527-532.
10. Hubert D, Brunswick P, Calvet JH, Dusser D, Fajac I: Abnormal electrochemical skin conductance in cystic fibrosis. J Cyst Fibros 2011;10:15-20.
11. Schwarz P, Brunswick P, Calvet J-H: EZSCAN a new technology to detect diabetes risk. Br J Diabetes Vasc Dis 2011;11:204-209.
12. Brunswick P, Mayaudon H, Albin V, Lair V, Ringuede A, Cassir M: Use of Ni electrodes chronoamperometry for improved diagnostics of diabetes and cardiac diseases. Conf Proc IEEE Eng Med Biol Soc 2007;2007:4544-4547.
13. Ayoub H, Grivewau S, Lair V, Brunswick P, Cassir M, Bedioui F: Electrochemical characterization of nickel electrodes in phosphate and carbonate electrolytes in view of assessing a medical diagnostic device for detection of early diabetes. Electroanalysis 2010;22:2483-2490.
14. Dyck PJ: Detection, characterization and staging of polyneuropathy: assessed in diabetes. Muscle Nerve 1988;11:21-32.
15. Casellini CM, Barlow PM, Rice AL, Casey M, Simmons K, Pittenger G, Bastyr EJ III, Wolka AM, Vinik AI: A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-b inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. Diabetes Care 2007;30:896-902.
16. Vinik AI, Erbas T, Park TS: Methods for evaluation of peripheral neurovascular dysfunction. Diabetes Technol Ther 2001;3:29-50.
17. Witzke K, Vinik A, Grant L, Parson H, Pittenger G: Loss of RAGE defense: a cause of Charcot neuroarthropathy Diabetes Care 2011;34:1617-1621.
18. Vinik AI, Ziegler D: Diabetic cardiovascular autonomic neuropathy. Circulation 2007;115:387-397.
19. Lieb DC, Parson HK, Mamikunian G, Vinik AI: Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammation. Exp Diabetes Res 2012;2012:878760.
20. La Rovere MT, Pinna GD, Maestri R, Sleight P: Clinical value of baroreflex sensitivity. Neth Heart J 2013;21:61-63.
21. Moak JP, Goldstein DS, Eldadah BA, Saleem A, Holmes C, Pechnik S, Sharabi Y: Supine low-frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation. Heart Rhythm 2007;4:1523-1529.
22. Moak JP, Goldstein DS, Eldadah BA, Saleem A, Holmes C, Pechnik S, Sharabi Y: Supine low-frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation. Cleve Clin J Med 2009;76(Suppl 2): S51-S59.
23. Calvet JH, Dupin J, Winiecki H, Schwarz PEH: Assessment of small fiber neuropathy through a quick, simple and non invasive method in a German diabetes outpatient clinic. Exp Clin Endocrinol Diabetes 2012;120:1-4.
24. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJB, O'Brien PC, Albers JW, Andersen H, Bolton CF, England JD, Klein CJ, Llewelyn JG, Mauermann ML, Russell JW, Singer W, Smith AG, Tesfaye S, Vella A: Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve 2010;42:157-164.
25. Yajnik CS, Kantikar VV, Pande AJ, Deslypere JP: Quick and simple evaluation of sudomotor function for screening of diabetic neuropathy. ISRN Endocrinol 2012;2012: 103714.
26. Calvet JH, Raisanen A, Eklund J, Brunswick P, Schwarz P: Assessment of sudomotor function as a tool for cardiorespiratory fitness level evaluation: comparison with VO2 max. Presented at the European Association for the Study of Diabetes Meeting, Lisbon, Portugal, September 2011.